CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

re: Ann: Omacetaxine European rights licensed... sounds like...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Raider1969
    312 Posts.
    clock Created with Sketch.
    14/12/09
    09:06
    Post #: 6038788
    re: Ann: Omacetaxine European rights licensed... sounds like good news to me
    CXS Price at posting: 93.0¢ Sentiment: ST Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS Sierra Nevada raises $2M for silver exploration at Blackhawk
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.